Movalis (Meloxicam)

Meloxicam, the active ingredient in Movalis, is an Oxicam (NSAID) presented as an injectable solution for intramuscular use. It is employed to relieve pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, acute musculoskeletal pain, and postoperative pain in adult patients.

GNH USA supplies Movalis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam acts as a non‑steroidal anti‑inflammatory agent to manage pain and inflammation in several musculoskeletal conditions.

- Osteoarthritis: reduces joint pain and swelling, improving mobility. - Rheumatoid arthritis: alleviates systemic inflammation and joint discomfort. - Acute musculoskeletal pain: provides rapid relief of injury‑related pain. - Postoperative pain: controls pain and inflammation after surgical procedures.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Injection‑site pain or erythema. - Mild skin rash. - Peripheral edema.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Acute renal impairment or failure. - Severe cutaneous reactions (e.g., Stevens‑Johnson syndrome). - Hepatic dysfunction with elevated enzymes. - Anaphylactic or severe hypersensitivity reactions.

Before initiating therapy, clinicians should consider patient‑specific factors and monitor for adverse events. - Renal function: assess baseline creatinine and monitor during treatment. - Hepatic function: check liver enzymes periodically. - Cardiovascular risk: evaluate history of heart disease or stroke. - Elderly patients: use the lowest effective dose and monitor closely. - Known hypersensitivity: avoid in patients with prior meloxicam or oxicam allergy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meloxicam may interact with several drug classes, requiring careful management. Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Lithium: elevated serum lithium levels. Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may potentiate renal adverse effects.